Compare FMC Corp (FMC) vs Paychex, Inc. (PAYX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Paychex, Inc. — how do they compare? FMC Corp trades at $11.54 (market cap $1.36B), while Paychex, Inc. trades at $114.03 (market cap $39.12B). The key difference: Paychex, Inc. is far larger — about 28.8× FMC Corp's market cap, and Paychex, Inc. pays the higher dividend (4.33%). Which is the better fit depends on your goals.
| FMC | PAYX | |
|---|---|---|
Market Cap | $1.36B | $39.12B |
Sector | Basic Materials | Industrials |
52-Week High | $43.90 | $147.99 |
52-Week Low | $10.72 | $85.57 |
Enterprise Value | $5.50B | $42.60B |
Dividend Yield | 2.95% | 4.33% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $10.72, down 1.74% on the day, reflecting ongoing challenges despite recent strategic moves. The stock shows a bearish technical trend with oversold RSI signals, while fundamentals reveal significant pressure with a net income margin of -72.93% and negative ROE of -80.78% for 2025. Recent developments include a $400 million minority investment from Tessenderlo Group and regulatory submission for new herbicide rimisoxafen, providing some operational support amid financial restructuring.
The outlook remains cautious with analyst consensus leaning neutral (50% Hold) despite a $16 price target suggesting 49% upside. Key risks include persistent revenue declines, high debt levels, and negative cash flow from operations. Investment opportunity exists if new product approvals and debt reduction efforts successfully stabilize profitability, but current financial metrics indicate substantial execution risk near term.
Paychex (PAYX) trades at $109.52, down 1.11% today but near the consensus price target of $110. The stock shows strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.32 beating estimates. Technical indicators are bullish on moving averages while oscillators remain neutral. Recent news highlights AI expansion and strong small business job growth, supporting the positive outlook.
PAYX presents a balanced investment case with robust profitability (27% net margin) and dividend appeal, though valuation multiples appear elevated. Key risks include macroeconomic sensitivity to small business hiring and competitive pressures. Analyst sentiment is mixed with 63% hold ratings, suggesting cautious optimism amid current price levels near fair value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Paychex, Inc.
Paychex is a leading provider of payroll, human capital management, and insurance solutions servicing small and midsize clients primarily in the United States. The company, established in 1979, services over 730,000 clients and pays over 1 in 12 U.S. private-sector workers. Alongside its traditional payroll services, Paychex offers HCM solutions such as benefits administration and time and attendance software, as well as human resources outsourcing and insurance agency services.
Read more on PAYX →
